Developer docs
API playgroundTry for free, no card

Search company profiles

AI ANALYTICS AND INTEGRATIONS LTD

Full company profile

uuid028u4bw

Namestring
AI ANALYTICS AND INTEGRATIONS LTD
Websiteurl
eileen.ai
Company typeenum
Private
Founded yearint
2020
Descriptiontext

AI Analytics and Integrations Ltd is a privately held, for-profit technology company founded in 2020 and headquartered in London, United Kingdom. According to its firmographic description, the company develops AI-powered software for health data analytics with a specific product focus on personalized diabetes management. Its web presence is centered on the eileen.ai domain, suggesting a consumer- or patient-facing platform orientation, although the primary source page only returned a verification/loader page and did not expose substantive product detail.

The underlying technology stack is not disclosed in the available input: core_technology, proprietary_features, ai_modalities, integrations, api_details, and products_and_services are all empty in the data set. The company's positioning implies machine-learning-driven analytics applied to health data inputs to produce personalized outputs for diabetes patients or their care teams, but no model architecture, data sources, training approach, validation evidence, or clinical evidence is documented in the materials reviewed.

The business model is similarly undocumented. There is no disclosed pricing model, no listed customer segments, no named customers, no marketing or distribution channels, no partnership or alliance data, and no compliance or certification information. revenue_model, pricing_details, customer_segments.segments, select_customers, and partnerships_and_alliances are all empty. As a result, the monetization mechanics — whether consumer subscription, payer/insurer contracts, B2B enterprise licensing to providers or pharma, or another model — cannot be determined from the available evidence, and the company should be treated as data-thin on commercial operations until primary documentation is obtained.

Short descriptiontext

AI Analytics and Integrations Ltd is a London-based company, founded in 2020, that develops AI-powered software for health data analytics with a focus on personalized diabetes management, operating under the eileen.ai brand.

Ownership categoryenum
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
AI health analytics, diabetes management software, health data analytics, personalized health insights, AI clinical software
Industry3 codes
PRIMARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Software Publishers51321
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Computer Programming Services7371
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Healthcare Analytics Software
No data
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

AI Analytics and Integrations Ltd develops AI-powered software for health data analytics and personalized diabetes management. The company applies artificial intelligence to health data to support individualized diabetes care and related clinical decision-making.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Consumer diabetes management app with bolus calculator and data analytics, owned by Roche. Directly comparable to AI Analytics and Integrations on personalized diabetes software plus health data analytics.

TypeDirect peer
Description

Diabetes data analytics platform that aggregates data from multiple CGMs, pumps, and apps. Directly comparable on the health data analytics side of the company's offering.

TypeDirect peer
Description

Digital therapeutics company with a diabetes prevention and management program delivered via AI-personalized coaching. Comparable on digital therapeutics for diabetes and chronic disease personalization.

TypeDirect peer
Description

AI-enabled virtual care platform for type 2 diabetes reversal. Comparable on AI-augmented personalized diabetes outcomes, with stronger clinical evidence scale.

TypeDirect peer
Description

Non-profit diabetes data platform supporting multiple device integrations and clinician analytics. Comparable on the health data analytics and diabetes interoperability layer.

6Abbott (FreeStyle Libre)
TypeBroad incumbent
Description

Maker of FreeStyle Libre CGM with the LibreView and LibreLink diabetes management apps. Comparable as a broad incumbent combining hardware plus diabetes analytics software.

7Better Therapeutics
TypeDirect peer
Description

Digital therapeutics company pursuing FDA-authorized software for type 2 diabetes. Comparable on the regulatory-grade personalized diabetes software positioning.

TypeBroad incumbent
Description

Includes the Livongo diabetes management program at scale, blending connected devices, coaching, and AI-personalized insights. Comparable as a broad incumbent in personalized diabetes management.

TypeBroad incumbent
Description

Leading CGM manufacturer whose CLARITY diabetes management software integrates glucose analytics. Comparable as an incumbent in the diabetes data analytics and management space with much broader hardware scale.

TypeDirect peer
Description

AI-driven diabetes management and coaching platform with predictive glucose insights. Closely comparable on the AI-powered personalized diabetes management positioning.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AI ANALYTICS AND INTEGRATIONS LTD

Healthcare Analytics Softwareeileen.ai

AI Analytics and Integrations Ltd is a London-based company, founded in 2020, that develops AI-powered software for health data analytics with a focus on personalized diabetes management, operating under the eileen.ai brand.

What AI ANALYTICS AND INTEGRATIONS LTD does

AI Analytics and Integrations Ltd is a privately held, for-profit technology company founded in 2020 and headquartered in London, United Kingdom. According to its firmographic description, the company develops AI-powered software for health data analytics with a specific product focus on personalized diabetes management. Its web presence is centered on the eileen.ai domain, suggesting a consumer- or patient-facing platform orientation, although the primary source page only returned a verification/loader page and did not expose substantive product detail.

The underlying technology stack is not disclosed in the available input: core_technology, proprietary_features, ai_modalities, integrations, api_details, and products_and_services are all empty in the data set. The company's positioning implies machine-learning-driven analytics applied to health data inputs to produce personalized outputs for diabetes patients or their care teams, but no model architecture, data sources, training approach, validation evidence, or clinical evidence is documented in the materials reviewed.

The business model is similarly undocumented. There is no disclosed pricing model, no listed customer segments, no named customers, no marketing or distribution channels, no partnership or alliance data, and no compliance or certification information. revenue_model, pricing_details, customer_segments.segments, select_customers, and partnerships_and_alliances are all empty. As a result, the monetization mechanics — whether consumer subscription, payer/insurer contracts, B2B enterprise licensing to providers or pharma, or another model — cannot be determined from the available evidence, and the company should be treated as data-thin on commercial operations until primary documentation is obtained.

AI ANALYTICS AND INTEGRATIONS LTD firmographics

Firmographics
Name
AI ANALYTICS AND INTEGRATIONS LTD
Website
https://eileen.ai
Company type
Private
Founded year
2020
Short description
AI Analytics and Integrations Ltd is a London-based company, founded in 2020, that develops AI-powered software for health data analytics with a focus on personalized diabetes management, operating under the eileen.ai brand.
Ownership category
akta.pro rank

AI ANALYTICS AND INTEGRATIONS LTD industry classification

Industry
Product category
Healthcare Analytics Software
NAICS
Software Publishers (51321), Custom Computer Programming Services (541511)
SIC
Services-Computer Programming Services (7371), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • AI health analytics
  • Diabetes management software
  • Health data analytics
  • Personalized health insights
  • AI clinical software

Where AI ANALYTICS AND INTEGRATIONS LTD is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

AI ANALYTICS AND INTEGRATIONS LTD business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations

AI ANALYTICS AND INTEGRATIONS LTD product offering

Product offering

Core offering

AI Analytics and Integrations Ltd develops AI-powered software for health data analytics and personalized diabetes management. The company applies artificial intelligence to health data to support individualized diabetes care and related clinical decision-making.

Differentiator

Problem solved

Functional benefit

Companies that use AI ANALYTICS AND INTEGRATIONS LTD

Customer profile

Ideal customer profiles1 record

AI ANALYTICS AND INTEGRATIONS LTD technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI ANALYTICS AND INTEGRATIONS LTD partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

AI ANALYTICS AND INTEGRATIONS LTD competitors and assessment

Company assessment

Direct peers

  • mySugr (Roche): Consumer diabetes management app with bolus calculator and data analytics, owned by Roche. Directly comparable to AI Analytics and Integrations on personalized diabetes software plus health data analytics.
  • Glooko: Diabetes data analytics platform that aggregates data from multiple CGMs, pumps, and apps. Directly comparable on the health data analytics side of the company's offering.
  • Omada Health: Digital therapeutics company with a diabetes prevention and management program delivered via AI-personalized coaching. Comparable on digital therapeutics for diabetes and chronic disease personalization.
  • Virta Health: AI-enabled virtual care platform for type 2 diabetes reversal. Comparable on AI-augmented personalized diabetes outcomes, with stronger clinical evidence scale.
  • Tidepool: Non-profit diabetes data platform supporting multiple device integrations and clinician analytics. Comparable on the health data analytics and diabetes interoperability layer.
  • Better Therapeutics: Digital therapeutics company pursuing FDA-authorized software for type 2 diabetes. Comparable on the regulatory-grade personalized diabetes software positioning.
  • One Drop: AI-driven diabetes management and coaching platform with predictive glucose insights. Closely comparable on the AI-powered personalized diabetes management positioning.

Broad incumbents

  • Abbott (FreeStyle Libre): Maker of FreeStyle Libre CGM with the LibreView and LibreLink diabetes management apps. Comparable as a broad incumbent combining hardware plus diabetes analytics software.
  • Teladoc Health (Livongo): Includes the Livongo diabetes management program at scale, blending connected devices, coaching, and AI-personalized insights. Comparable as a broad incumbent in personalized diabetes management.
  • Dexcom: Leading CGM manufacturer whose CLARITY diabetes management software integrates glucose analytics. Comparable as an incumbent in the diabetes data analytics and management space with much broader hardware scale.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

AI ANALYTICS AND INTEGRATIONS LTD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AI ANALYTICS AND INTEGRATIONS LTD leadership team

Management profile

Number of profiles

AI ANALYTICS AND INTEGRATIONS LTD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AI ANALYTICS AND INTEGRATIONS LTD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AI ANALYTICS AND INTEGRATIONS LTD

What does AI ANALYTICS AND INTEGRATIONS LTD do?

AI Analytics and Integrations Ltd develops AI-powered software for health data analytics and personalized diabetes management. The company applies artificial intelligence to health data to support individualized diabetes care and related clinical decision-making.

When was AI ANALYTICS AND INTEGRATIONS LTD founded?

AI ANALYTICS AND INTEGRATIONS LTD was founded in 2020.

Where is AI ANALYTICS AND INTEGRATIONS LTD based?

AI ANALYTICS AND INTEGRATIONS LTD is headquartered in London, United Kingdom, in the Europe region.

Who are AI ANALYTICS AND INTEGRATIONS LTD's main competitors?

Direct peers on record are mySugr (Roche), Glooko, Omada Health, Virta Health, Tidepool, Better Therapeutics and One Drop. Broad incumbents are Abbott (FreeStyle Libre), Teladoc Health (Livongo) and Dexcom.

Does AI ANALYTICS AND INTEGRATIONS LTD have an API?

No public API is recorded for AI ANALYTICS AND INTEGRATIONS LTD.

What industry is AI ANALYTICS AND INTEGRATIONS LTD in?

AI ANALYTICS AND INTEGRATIONS LTD's product category is Healthcare Analytics Software. Its primary akta.pro industry code is HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators), with a secondary code of BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 51321 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales